{
    "nctId": "NCT03229824",
    "briefTitle": "Use of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical Trial",
    "officialTitle": "Randomized Controlled Trial to Reduce Surgical Site Infections in Breast Cancer Surgery With Clorhexidine Gluconate Securement Dressing (Tegaderm CHG)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 116,
    "primaryOutcomeMeasure": "Number of subjects with drain bulb fluid bacterial colonization at the first and second week postoperative.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Females minimum age 18 able to give informed consent\n* Breast cancer confirmed by histopathology\n* Patients undergoing unilateral or bilateral mastectomy with or without immediate expander reconstruction.\n\nExclusion Criteria:\n\n* Males\n* Patients who deny informed consent\n* Prior radiation therapy to the sick breast.\n* Pregnant or breastfeeding women\n* Patients undergoing immediate breast reconstruction with Deep Inferior\n* Epigastric Perforator (DIEP) o Transverse Rectus Abdominal Muscle techniques (TRAM) .\n* Emergency procedures\n* Documented allergy to chlorhexidine gluconate\n* Antibiotic use in the fourteen days prior to surgical date\n* Patients with a history or suspicion of breast cancer surgery outside the INCan in the previous three months.\n* Patients who do not speak spanish, diagnosed with a psychiatric disorder and in whom a minimum follow-up of 14 days couldn't be feasible because of operative difficulties (eg.\n\nplace of residence or reference to other health institutions).",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}